Identifying Peptide Mimics of Tumor Antigens
Author Information
Author(s): Arnaiz Blanca, Madrigal-Estebas Laura, Todryk Stephen, James Tharappel C, Doherty Derek G, Bond Ursula
Primary Institution: Moyne Institute for Preventive Medicine, Department of Microbiology, University of Dublin, Trinity College, Dublin, Ireland
Hypothesis
Can synthetic mimic peptides of Hsp70-peptide complexes activate T-cells?
Conclusion
The study successfully identified synthetic mimic peptides that can stimulate immune responses against tumor antigens.
Supporting Evidence
- Peptides that bind to Hsp70-peptide complexes were identified through bio-panning.
- Synthetic peptides were shown to stimulate T-cell responses in vitro.
- DCs loaded with mimic peptides primed lymphocytes to respond to tumor cell extracts.
Takeaway
Researchers found new peptides that can help the immune system fight cancer by mimicking proteins from tumors.
Methodology
The study used bio-panning of a phage display library to identify peptides that mimic Hsp70-peptide complexes and tested their ability to activate T-cells.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website